Compare eBay Inc (EBAY) vs Viatris Inc (VTRS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
eBay Inc vs Viatris Inc — how do they compare? eBay Inc trades at $111.7 (market cap $49.83B), while Viatris Inc trades at $17.47 (market cap $20.03B). The key difference: eBay Inc is far larger — about 2.5× Viatris Inc's market cap, and Viatris Inc pays the higher dividend (2.75%). Which is the better fit depends on your goals — on Pluang, investors hold eBay Inc for 134 Days and Viatris Inc for 57 Days on average.
| EBAY | VTRS | |
|---|---|---|
Market Cap | $49.83B | $20.03B |
Volume | 2,986,953 | 14,109,977 |
Sector | Consumer Cyclical | Health |
52-Week High | $118.96 | $18.27 |
52-Week Low | $79.41 | $9.74 |
Typical Hold Time | 134 Days | 57 Days |
Enterprise Value | $53.65B | $32.15B |
Dividend Yield | 1.11% | 2.75% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EBAY trades at $107.60, up 0.5% with a bullish technical signal and strong recent earnings beats. The company maintains robust profitability with 72% gross margins and 18.6% net income margin, though revenue growth remains moderate. Analyst consensus is positive with a $117.68 price target, representing 9% upside potential. Recent news highlights strategic focus on collectibles and live commerce while navigating competitive pressures from Amazon's multi-platform seller tools.
EBAY presents a balanced opportunity with strong fundamentals and analyst support, though faces execution risks in growth initiatives and competitive threats. The stock's current valuation appears reasonable given earnings consistency, but investors should monitor advertising growth trends and GameStop's strategic stake in the company.
Viatris (VTRS) trades at $17.49, down 0.29% with a bullish technical signal and strong recent earnings beats. The company shows improving operational cash flow of $2.32B in 2025 and positive revenue growth trends, though profitability remains challenged with negative net margins. Recent developments include FDA approval for WAKIX in Japan and consistent dividend payments, supporting the bullish analyst consensus with a $22.17 price target representing 27% upside potential.
The outlook remains cautiously optimistic with strong cash generation supporting shareholder returns, but investors face risks from persistent negative profitability and high debt levels. The stock offers value appeal with reasonable P/S and P/B ratios, though the elevated P/E ratio reflects current earnings challenges that need resolution for sustained re-rating.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About eBay Inc
eBay Inc. is a global commerce company. The Company's platforms are designed to enable sellers worldwide to organize and offer their inventory for sale and buyers to find and buy it. eBay's items can be new or used, plain or luxurious, commonplace or rare, trendy or one-of-a-kind.
Read more on EBAY →About Viatris Inc
Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).
Read more on VTRS →
